Literature DB >> 11705004

Thyroid cancer following exposure to radioactive iodine.

J Robbins1, A B Schneider.   

Abstract

The thyroid gland is one of the most sensitive organs for radiation-induced oncogenesis and the magnitude of the risk from external radiation is well understood. This is not the case for internal radiation derived from the radioiodines, a matter of practical importance because of medical use and potential accidental exposure. This article reviews current knowledge derived from the follow-up of patients receiving diagnostic or therapeutic 131I and populations exposed to radioactive fallout. The latter includes the nuclear power station accident at Chernobyl and the results of atomic bomb development and testing at Hanford, the Nevada Test Site and the Marshall Islands. The most cogent information comes from Chernobyl where an epidemic of childhood thyroid cancer has followed exposure to radioiodine that was mainly 131I. Although much has been learned from this experience about the nature of radioiodine induced thyroid cancer in young children, the reconstruction of thyroid radiation doses is too preliminary to provide accurate knowledge of the risk in comparison to that from external radiation. In the Marshall Islands, much of the exposure was from short-lived radioiodines as well as external radiation, obviating the possibility to determine the risk from 131I. Exposure to 131I in the continental United States from atomic bomb testing is expected to have caused some thyroid cancers, but only in the immediate vicinity of the Nevada Test Site has any evidence of radiation-induced thyroid neoplasms been adduced. This evidence is minimally significant statistically, and not significant for thyroid cancer per se. Medical use of radioiodine has not been observed to cause thyroid cancer but very few of the patients studied were young children, the group most sensitive to thyroid radiation. Despite these limitations, this information is sufficient to make some suggestions concerning protective measures in the case of nuclear accidents and the follow up of individuals who have been exposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11705004     DOI: 10.1023/a:1010031115233

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  37 in total

Review 1.  Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use.

Authors:  D V Becker; P Zanzonico
Journal:  Thyroid       Date:  1997-04       Impact factor: 6.568

Review 2.  Thyroid consequences of Chernobyl accident in the countries of the European Community.

Authors:  J Malone; J Unger; F Delange; R Lagasse; J E Dumont
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

3.  Hanford Environmental Dose Reconstruction Project--an overview.

Authors:  D B Shipler; B A Napier; W T Farris; M D Freshley
Journal:  Health Phys       Date:  1996-10       Impact factor: 1.316

4.  Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation.

Authors:  A B Schneider; C Bekerman; J Leland; J Rosengarten; H Hyun; B Collins; E Shore-Freedman; T C Gierlowski
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

5.  Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study.

Authors:  J A Franklyn; P Maisonneuve; M Sheppard; J Betteridge; P Boyle
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

6.  Protracted exposure to fallout: the Rongelap and Utirik experience.

Authors:  E T Lessard; R P Miltenberger; S H Cohn; S V Musolino; R A Conard
Journal:  Health Phys       Date:  1984-03       Impact factor: 1.316

7.  Radiation doses from Hanford Site releases to the atmosphere and the Columbia River.

Authors:  W T Farris; B A Napier; T A Ikenberry; D B Shipler
Journal:  Health Phys       Date:  1996-10       Impact factor: 1.316

8.  Radioiodine-induced thyroid cancer: Studies in the aftermath of the accident at Chernobyl.

Authors:  J Robbins; A B Schneider
Journal:  Trends Endocrinol Metab       Date:  1998-04       Impact factor: 12.015

9.  A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.

Authors:  R A Kerber; J E Till; S L Simon; J L Lyon; D C Thomas; S Preston-Martin; M L Rallison; R D Lloyd; W Stevens
Journal:  JAMA       Date:  1993-11-03       Impact factor: 56.272

10.  Iodine-131 therapy of hyperthyroidism in pediatric patients.

Authors:  J D Clark; M J Gelfand; A H Elgazzar
Journal:  J Nucl Med       Date:  1995-03       Impact factor: 10.057

View more
  9 in total

1.  "Re: Radiation protection in pediatric radiology".

Authors:  Haluk Söylemez; Ahmet Ali Sancaktutar; Bulent Altunoluk; Murat Atar
Journal:  Urol Res       Date:  2012-02-25

Review 2.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

3.  Superoxide production by a manganese-oxidizing bacterium facilitates iodide oxidation.

Authors:  Hsiu-Ping Li; Benjamin Daniel; Danielle Creeley; Russell Grandbois; Saijin Zhang; Chen Xu; Yi-Fang Ho; Kathy A Schwehr; Daniel I Kaplan; Peter H Santschi; Colleen M Hansel; Chris M Yeager
Journal:  Appl Environ Microbiol       Date:  2014-02-21       Impact factor: 4.792

4.  Current attitudes of Turkish anesthesiologists to radiation exposure.

Authors:  Adnan Tüfek; Orhan Tokgöz; Ilker Öngüç Aycan; Feyzi Çelik; Abdurrahman Gümüş
Journal:  J Anesth       Date:  2013-05-08       Impact factor: 2.078

Review 5.  Graves disease in childhood: a review of the options for diagnosis and treatment.

Authors:  Jorg Dötsch; Wolfgang Rascher; Helmuth G Dörr
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 6.  Acute Radiation Syndrome and the Microbiome: Impact and Review.

Authors:  Brynn A Hollingsworth; David R Cassatt; Andrea L DiCarlo; Carmen I Rios; Merriline M Satyamitra; Thomas A Winters; Lanyn P Taliaferro
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

7.  The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.

Authors:  Luca Lavra; Cinzia Rinaldo; Alessandra Ulivieri; Emidio Luciani; Paolo Fidanza; Laura Giacomelli; Carlo Bellotti; Alberto Ricci; Maria Trovato; Silvia Soddu; Armando Bartolazzi; Salvatore Sciacchitano
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

Review 8.  Radiation and Thyroid Cancer.

Authors:  Elisabetta Albi; Samuela Cataldi; Andrea Lazzarini; Michela Codini; Tommaso Beccari; Francesco Saverio Ambesi-Impiombato; Francesco Curcio
Journal:  Int J Mol Sci       Date:  2017-04-26       Impact factor: 5.923

Review 9.  Medical Therapy of Patients Contaminated with Radioactive Cesium or Iodine.

Authors:  Jan Aaseth; Valeria Marina Nurchi; Ole Andersen
Journal:  Biomolecules       Date:  2019-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.